Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.80
+$0.06 (+8.11%)
After-hours:
Sep 21, 2026, 7:50 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 14.6M | 22.85M | 21.61M | 28.79M | 53.08M | 89.02M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 40.17K | 40.72K | n/a | n/a | n/a |
Other Long-Term Assets | 312.35K | 281.66K | n/a | 0 | 29.37K | 29.38K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 961.9K | 726.25K | 914.28K | 1.37M | n/a | n/a |
Total Current Assets | 15.56M | 23.58M | 22.52M | 30.15M | 56.58M | 92.42M |
Property-Plant & Equipment | 59.81K | 81.52K | 88.36K | 2.32K | 209.68K | 359.13K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 372.16K | 403.35K | 129.08K | 2.32K | 239.05K | 388.51K |
Total Assets | 15.93M | 23.98M | 22.65M | 30.16M | 56.82M | 92.81M |
Account Payables | 713.67K | 1.35M | 1.67M | 842.75K | 1.77M | 4.5M |
Deferred Revenue | n/a | n/a | 528.97K | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 770.56K | 465.02K | 1.17M | 960.36K | 1.42M | 1.52M |
Total Current Liabilities | 2.76M | 3.36M | 4.39M | 3.2M | 7.32M | 15.33M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 727.36K | 1.31M | 1.31M | 1.31M | n/a | n/a |
Total Long-Term Liabilities | 727.36K | 1.31M | 1.31M | 1.31M | n/a | 78.85K |
Total Liabilities | 3.49M | 4.67M | 4.39M | 4.51M | 7.32M | 15.41M |
Total Debt | n/a | n/a | n/a | n/a | 190.47K | 335.16K |
Book Value | 12.44M | 19.31M | 18.26M | 25.64M | 49.51M | 77.4M |
Book Value Per Share | 1.90 | 3.50 | 5.05 | 309.51 | 46.51 | 73.24 |
Common Stock | 8.19K | 5.48K | 3.74K | 2.66K | 1.09K | 21.19K |
Retained Earnings | -333.64M | -321.04M | -308.08M | -293.8M | -181.13M | -144.01M |
Comprehensive Income | -10.63M | -10.63M | -10.61M | -10.62M | -10.36M | -10.04M |
Shareholders Equity | 12.44M | 19.31M | 18.26M | 25.64M | 49.51M | 77.4M |
Total Investments | n/a | 40.17K | 40.72K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove APRE